SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jurgis Bekepuris who wrote (15193)8/14/2002 6:49:11 PM
From: Paul Senior  Read Replies (3) of 78599
 
Jurgis Bekepuris, okay -g-, if you're no Grahammite, let's try Buffett.

Do you have a way to relate ROE to price to book value for these three companies? I'm looking for an opinion - based primarily on those figures and relationship - to indicate whether the stocks are now buys or sells.

DOV. Current price 28 in a range roughly between 26 and 43.
I'll superficially guess ROE is about 20-23%. Sells about 2.45x its approx. $11 book value.

HRB. Current price about 48 in a range roughly between 32-51. Maybe 20-25% ROE. Selling at 6x book value of $7.56.

NKE. Current price about 44 in a range about 41-64. Past few years' ROE roughly 12-18%. Selling at 3x book value of 14.

I call DOV very close to being a buy based on its historical ROE, its current book value, and its current price. (Given current interest rates. I've not looked at debt, eps, other factors.) The other two stocks are, if they're not overpriced, they're not bargains either. What's your opinion? (Or anyone else who might care to comment on these stocks.)

finance.yahoo.com

Stocks were picked from last pages of following filing:
sec.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext